Welcome to LookChem.com Sign In|Join Free
  • or
3-IODO-6-METHYL-IMIDAZO[1,2-A]PYRIDINE is a heterocyclic chemical compound with the molecular formula C8H7IN2. It is derived from imidazo[1,2-a]pyridine, an aromatic organic compound, and is characterized by the presence of an iodo substituent at the 3-position and a methyl group at the 6-position. This unique structure endows it with potential applications in medicinal chemistry and drug development, making it a promising candidate for research in drug discovery and development.

885276-23-3

Post Buying Request

885276-23-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

885276-23-3 Usage

Uses

Used in Medicinal Chemistry:
3-IODO-6-METHYL-IMIDAZO[1,2-A]PYRIDINE is used as a building block in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic effects.
Used in Drug Development:
3-IODO-6-METHYL-IMIDAZO[1,2-A]PYRIDINE is used as a target for research in drug discovery and development. Its potential biological activities and interactions with biological targets make it a valuable compound for exploring new therapeutic agents.
Used in Pharmaceutical Industry:
3-IODO-6-METHYL-IMIDAZO[1,2-A]PYRIDINE is used as a key intermediate in the synthesis of pharmaceutical compounds. Its unique structure and potential biological effects contribute to the development of innovative drugs with improved efficacy and safety profiles.

Check Digit Verification of cas no

The CAS Registry Mumber 885276-23-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,7 and 6 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 885276-23:
(8*8)+(7*8)+(6*5)+(5*2)+(4*7)+(3*6)+(2*2)+(1*3)=213
213 % 10 = 3
So 885276-23-3 is a valid CAS Registry Number.

885276-23-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-iodo-6-methylimidazo[1,2-a]pyridine

1.2 Other means of identification

Product number -
Other names 3-IODO-6-METHYL-IMIDAZO[1,2-A]PYRIDINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:885276-23-3 SDS

885276-23-3Downstream Products

885276-23-3Relevant academic research and scientific papers

From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase

Juillet, Charlotte,Ermolenko, Ludmila,Boyarskaya, Dina,Baratte, Blandine,Josselin, Béatrice,Nedev, Hristo,Bach, Stéphane,Iorga, Bogdan I.,Bignon, Jér?me,Ruchaud, Sandrine,Al-Mourabit, Ali

, p. 1197 - 1219 (2021/02/05)

Significant inhibition of Aurora B was achieved by the synthesis of simplified fragments of benzosceptrins and oroidin belonging to the marine pyrrole-2-aminoimidazoles metabolites isolated from sponges. Evaluation of kinase inhibition enabled the discovery of a synthetically accessible rigid acetylenic structural analogue EL-228 (1), whose structure could be optimized into the potent CJ2-150 (37). Here we present the synthesis of new inhibitors of Aurora B kinase, which is an important target for cancer therapy through mitosis regulation. The biologically oriented synthesis yielded several nanomolar inhibitors. The optimized compound CJ2-150 (37) showed a non-ATP competitive allosteric mode of action in a mixed-type inhibition for Aurora B kinase. Molecular docking identified a probable binding mode in the allosteric site "F"and highlighted the key interactions with the protein. We describe the improvement of the inhibitory potency and specificity of the novel scaffold as well as the characterization of the mechanism of action.

IMIDAZO[1,2-α ]PYRIDINYL BISPHOSPHONATES

-

Page/Page column 30, (2010/04/25)

Novel imidazo[1,2-α]pyridinyl bisphosphonate compounds are disclosed, as well as methods of preparing the compounds, pharmaceutical compositions including the compounds, and administration of the compounds in methods of treating abnormal calcium and phosphate metabolism, including bone and joint diseases and other disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 885276-23-3